Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors
Ramesh K Ramanathan, D Lynn Kirkpatrick, Chandra P Belani, et al.
Antimicrobial Agents and Chemotherapy
|
November 5, 2014
Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections
Sujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 5, 2006
Spontaneous CD4+ T cell responses against TRAG-3 in patients with melanoma and breast cancers
Bratislav Janjic, Pedro Andrade, Xiao-Fei Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 3, 2016
Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team
Charles Knirsch, Demissie Alemayehu, Radu Botgros, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2008
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms
Martin E Stryjewski, Donald R Graham, Samuel E Wilson, et al.
Clinical Genitourinary Cancer
|
December 25, 2013
A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma
David S Hong, Michael S Gordon, Wolfram E Samlowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers
Ramesh K Ramanathan, Merrill J Egorin, Julie L Eiseman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 15, 2010
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens
Ethan Rubinstein, Tahaniyat Lalani, G Ralph Corey, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors
Ramesh K Ramanathan, D Lynn Kirkpatrick, Chandra P Belani, et al.
Antimicrobial Agents and Chemotherapy
|
November 5, 2014
Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections
Sujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 5, 2006
Spontaneous CD4+ T cell responses against TRAG-3 in patients with melanoma and breast cancers
Bratislav Janjic, Pedro Andrade, Xiao-Fei Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 3, 2016
Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team
Charles Knirsch, Demissie Alemayehu, Radu Botgros, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2008
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms
Martin E Stryjewski, Donald R Graham, Samuel E Wilson, et al.
Clinical Genitourinary Cancer
|
December 25, 2013
A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma
David S Hong, Michael S Gordon, Wolfram E Samlowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers
Ramesh K Ramanathan, Merrill J Egorin, Julie L Eiseman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 15, 2010
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens
Ethan Rubinstein, Tahaniyat Lalani, G Ralph Corey, et al.
Page
of 6